BriaCell Therapeutics’ stock surged on Wednesday after the company announced encouraging overall survival data from its Phase 2 clinical trial of Bria-IMT in combination with an immune checkpoint inhibitor (CPI) for late-stage metastatic breast cancer. The data revealed a significant improvement in survival compared to previously reported findings and similar patients treated with other methods.
India’s drug regulator has suspended the approval granted to Entod Pharmaceutical Ltd. to manufacture PresVu eye drops, citing the company’s unapproved claims that the drops reduce dependency on reading glasses. The regulator raised concerns about the safety of the eye drops and their over-the-counter use, as they were approved as a prescription drug. Entod Pharmaceuticals has disputed the suspension and plans to challenge the order in court.
The King Faisal Specialist Hospital & Research Centre (KFSHRC) will be a key partner at the 2024 NYC C3 Summit Davos of Healthcare, focusing on tech-driven healthcare advancements and global challenges. The summit will bring together healthcare leaders from the US and the Arab world for discussions and collaboration.
Learn about the stress hormone cortisol, its benefits and downsides, and how to manage your stress levels with actionable tips and dietary recommendations from a neuroscientist.
Applied DNA Sciences, through its subsidiary Applied DNA Clinical Labs (ADCL), has expanded its clinical testing services for mpox, leading to a 37% surge in its stock price. The new service now includes detection of both Mpox Clade I and Clade II, aiming to bolster efforts to combat the rising mpox threat.
The ongoing strike by junior doctors in West Bengal enters its 33rd day as tensions rise. Doctors have demanded a meeting with Chief Minister Mamata Banerjee, with specific conditions including live broadcast of the discussion. The strike, initially sparked by the alleged rape and murder of a fellow doctor, has evolved to include broader calls for improved security and greater representation for healthcare professionals.
Regeneron Pharmaceuticals and Sanofi announced positive results from multiple Phase 3 trials of their drug Dupixent, demonstrating its effectiveness in treating chronic skin conditions like chronic spontaneous urticaria (CSU) and bullous pemphigoid. These findings could lead to expanded approval for Dupixent to treat a wider range of skin conditions.
Johnson & Johnson’s Rybrevant, a lung cancer treatment, continues to demonstrate positive results. A new study shows that a prophylactic strategy significantly reduces infusion-related reactions, while long-term data from the MARIPOSA study reinforces Rybrevant’s effectiveness in combination with Lazcluze, improving survival and disease control compared to standard treatment.
TriAgenics’ Zero3 TBA technology offers a potential game-changer for wisdom teeth management. This innovative, minimally invasive procedure aims to prevent wisdom teeth from developing altogether, eliminating the need for costly and painful extractions. The technology could dramatically reduce the financial and physical burdens associated with wisdom teeth, offering a safer and more cost-effective alternative to traditional methods.
ThinkLite Air, a leader in indoor air quality solutions, has partnered with Medxcel to improve patient safety at a Texas children’s hospital. The collaboration involved installing ThinkLite Air Purilux units and Flair monitors in the Oncology wing, leading to significant reductions in ultrafine pollution, coarse pollution, and volatile organic compounds. The successful implementation of this project has paved the way for expansion to other Medxcel facilities.
